E-Mail
Heidelberg/Germany and Cambridge/USA, 4 February 2021 - EMBO Press announces the appointment of immunologist Facundo Batista, PhD, as Chief Editor of
The EMBO Journal. Facundo Batista, who is a Professor at Harvard Medical School and the first Associate Director of the Ragon Institute of MGH, MIT and Harvard, Cambridge/USA, takes up the appointment with immediate effect. He takes over from Bernd Pulverer, Head of Scientific Publishing at EMBO after a decade in the role, who will lead EMBO Reports as Chief Editor. I am delighted to serve the wider scientific community by joining
The EMBO Journal as Chief Editor. It is an honor to partner with such an outstanding Editorial Board and excellent team of editors, who have continuously pioneered important new standards in scientific publishing. My goal is to build on the heritage of this flagship journal to better represent the biological sciences as they are practiced today, across disciplinary and international frontiers.
World-Renowned Cancer Researcher, Dr Alan Ashworth, Joins Phoenix Molecular Designs Advisory Board
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Credit: Irene Böttcher-Gajewski / Max Planck Institute for Biophysical Chemistry
The award is one of the most prestigious in Europe and endowed with 500,000 Swiss francs. With this prize the Louis-Jeantet Foundation honors the director at the Max Planck Institute (MPI) for Biophysical Chemistry for his pioneering work in the field of gene transcription. Transcription is a copying process enabling living cells to produce transcripts of their genes that then serve as blueprints for making proteins. Cramer s research focuses on the molecular machines, called RNA polymerases, that control this fundamental process of life. Patrick Cramer has visualized the structures of many of these cellular copying machines in atomic detail for the first time. He demonstrated how RNA polymerases translate genetic information and how they work as a team with other protein complexes. His ground-breaking research provides deep insights into gene transcription with unprecedented detail. It is highly des
OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board
USA - English
News provided by
Share this article
Share this article
BINYAMINA, Israel, Jan. 11, 2021 /PRNewswire/ OncoHost, global leader in host response profiling for improved personalized cancer therapy, announced today that renowned biologist and winner of The Nobel Prize in Chemistry, Professor Aaron Ciechanover, has joined the company s scientific advisory board. We are delighted to have Professor Ciechanover, an eminent researcher and physician, join our team. His profound scientific knowledge in protein biology and fundamental discoveries in protein turnover that awarded him the 2004 Nobel Prize in Chemistry will be an invaluable contribution to our research efforts in identifying effective personalized cancer treatments, said Dr. Ofer Sharon, CEO of OncoHost. OncoHost s unique approach to host response analysis and our methods to overcome therapy resistance will be further improved by Prof. Ciechan
vimarsana © 2020. All Rights Reserved.